US Justice Department Proposes Historic Reclassification of Marijuana

Regulations by 2FIRSTS.ai
May.17.2024
US Justice Department Proposes Historic Reclassification of Marijuana
U.S. Justice Department proposes historic reclassification of marijuana as safer drug, prompting potential benefits for research and cannabis industry.

According to a report by Reuters on May 17, the U.S. Department of Justice officially proposed a historic measure on Thursday (16th) to reclassify marijuana as a safer drug, stating that the risk of marijuana abuse is lower compared to other higher risk substances. If this regulation is enacted, it will also help facilitate further research on the medical benefits of marijuana.

 

The proposal states, "Furthermore, the FDA's review did not find any safety issues, indicating that the medical use of marijuana does not pose unacceptable high safety risks.

 

The Drug Enforcement Administration (DEA) in the United States is currently soliciting public feedback on the proposal, a process that may take some time, but Attorney General Merrick Garland has already given his approval. If approved, this new regulation would remove marijuana from the list of Schedule I drugs (which includes heroin, LSD, etc.) and reclassify it as a Schedule III drug, on par with ketamine and some synthetic steroids.

 

The department conducted a classification review of marijuana at the request of President Joe Biden in 2022. Additionally, Biden has taken steps to pardon thousands of individuals who were sentenced at the federal level for possession of marijuana, and has urged governors and mayors to take similar actions to commute these sentences. He hopes that this move will increase support for the Democratic party in an election year, especially among younger voters. Biden has promised, "Too many lives have been put in jeopardy due to the mishandling of marijuana, and I am committed to correcting these mistakes. You can trust my word."

 

Previously, the Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS) had recommended in August 2023 that the DEA classify marijuana as a Schedule III drug. The DEA has yet to make a specific classification for marijuana.

 

If the federal government relaxes marijuana classification, marijuana companies stand to benefit, such as being eligible to list on major stock exchanges and receive more generous tax breaks. Additionally, the banking restrictions they face may be reduced. Because marijuana is illegal at the federal level, most American banks do not provide loans or services to marijuana companies, prompting many banks to rely on cash transactions.

 

The public will have 60 days to submit comments on the proposal from the Department of Justice, and can also request a public hearing to be held on the proposal.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

South Africa Implements Stricter Regulations on E-Cigarettes
South Africa Implements Stricter Regulations on E-Cigarettes
South Africa's new tobacco plan includes stricter regulations for electronic cigarettes, aiming to discourage smoking, especially among children.
Oct.05 by 2FIRSTS.ai
Vladimir Region Ranks Top 10 in Russian E-Cigarette Consumption
Vladimir Region Ranks Top 10 in Russian E-Cigarette Consumption
Wikireality.ru reports Vladimir Oblast among Russia's top 10 regions for e-cigarette consumption, after Crimea and Sevastopol.
Aug.08 by 2FIRSTS.ai
West Virginia Launches "Don't Let Vaping Cloud It" Campaign
West Virginia Launches "Don't Let Vaping Cloud It" Campaign
West Virginia launches "Don't Let Vaping Cloud It" campaign in schools to educate students about the dangers of vaping.
Aug.25 by 2FIRSTS.ai
Washington Schools Installing E-Cigarette Alarms to Deter Student Usage
Washington Schools Installing E-Cigarette Alarms to Deter Student Usage
Several schools in Washington state have installed e-cigarette alarms in restrooms to discourage students from using them during school hours.
Regulations
Jan.31 by 2FIRSTS.ai
Brazilian Police Bust Illegal E-cigarette Operation in Propriá City
Brazilian Police Bust Illegal E-cigarette Operation in Propriá City
Brazilian police seize large quantities of illegal e-cigarettes in Propriá, with confiscated flavoring materials. Sellers charged with smuggling and corruption.
Regulations
Mar.12 by 2FIRSTS.ai
ARAC Chief Research Officer on PMTAs & U.S. Regulatory Environment: Age-Gating Useful, But Scientific Evaluation Critical; Companies Must Adapt to New FDA Requirements
ARAC Chief Research Officer on PMTAs & U.S. Regulatory Environment: Age-Gating Useful, But Scientific Evaluation Critical; Companies Must Adapt to New FDA Requirements
In response to FDA's recent memo on PMTA applications for non-tobacco flavored e-cigarettes, 2Firsts spoke with Dr. Jessica Zdinak, Chief Research Officer and CEO at ARAC. She explained the challenges in the FDA review process and stressed that while age-gating technology can help, it is not a substitute for scientific evaluation. Dr. Zdinak also urged manufacturers to increase investment in scientific research to meet FDA requirements.
Nov.26 by